TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A paper in The Lancet Healthy Longevity argues that sarcopenia should be understood as a disorder of the aging motor system, which includes the brain, spinal cord, nerves and muscles. The authors say muscle-focused explanations and treatments do not fully account for changes in strength and mobility, but the proposed approach still needs practical testing and validation.
A paper in The Lancet Healthy Longevity argues that age-related weakness and mobility loss should not be treated as muscle problems alone, but as possible signs of decline across the motor system—from the brain and spinal cord to nerves and muscle. The authors propose changes to how sarcopenia, the loss of muscle strength and physical function associated with aging, is assessed, while acknowledging that their suggested tests have not yet been shown to improve outcomes.
The authors, led by Lucas B. R. Orssatto, say muscle loss accounts for only a modest share of the strength decline seen with age. People with similar muscle amounts can have very different levels of strength and mobility, they write. They also point to research showing that exercise can improve strength and mobility without a measurable increase in muscle mass.
The paper describes movement as dependent on a connected system involving the brain, spinal cord, nerves and muscles. With aging, the authors say, movement planning may slow, nerve signals may become less reliable, and balance and position sense can decline. That may mean less effective communication between the nervous system and muscles, even when muscle remains present.
The researchers propose that clinicians look beyond muscle size and basic strength checks. Suggested observations include how quickly someone rises from a chair, whether they become unsteady during sustained effort, changes in hand dexterity, and whether walking changes when the person is also talking. They say weakness that is asymmetric, rapid or out of proportion to muscle loss may warrant closer examination. The paper also recommends reviewing medicines that can blunt motor drive, including sedatives and anticholinergic drugs.
A Broader View of Mobility Loss
The proposed shift could affect how clinicians investigate and treat older adults who are getting weaker or moving more slowly. If the problem involves several parts of the motor system, a plan focused only on building muscle may miss relevant causes or fail to address everyday tasks such as rising from a chair, walking steadily or carrying groceries.
The issue has public-health implications in Australia, where the source report says falls remain the leading cause of injury-related hospitalization and death. It reports 253,800 fall-related hospitalizations in 2024–25, and 6,722 deaths following falls in 2023–24; estimated health-system costs for fall injuries were $5.4 billion. These figures describe the burden of falls, not proof that the paper’s proposed framework would reduce them.
The authors argue that research and care should measure strength, movement and function, as well as muscle. Whether this approach leads to better outcomes remains untested, so the paper is a proposal for revising the framework rather than evidence that new screening methods or treatments work better.
Products Worth Considering
Garmin Forerunner 570 GPS Running Smartwatch, 47mm, Aluminum, Black
Coway Mighty AP-1512HH(W) Air Purifier, White
LEVOIT Vital 200S-P Smart Air Purifier for Large Rooms
As an affiliate, we earn on qualifying purchases.
How Sarcopenia Measures Shifted
Sarcopenia has traditionally been described as a loss of muscle associated with aging. The source report says diagnostic approaches have increasingly emphasized grip strength, gait speed and chair stands, because these measures predict falls, disability and death better than muscle mass alone. The authors argue, however, that the explanation for the condition has not kept pace with that change in measurement.
The report says sarcopenia affects up to 29% of community-dwelling older adults, with higher rates among people in hospitals or residential elder care and those with multiple health conditions or frailty. Separately, an Australian Journal of General Practice article published earlier in 2026 proposed an algorithm for screening, assessment and management of poor muscle health in primary care. The new paper adds a broader motor-system perspective to that clinical discussion.
“Reframing sarcopenia as a disease of the ageing motor system”
— Lucas B. R. Orssatto and co-authors, in The Lancet Healthy Longevity
Tests and Benefits Still Unproven
The authors acknowledge that the proposed observations have not been shown to outperform existing screening on health outcomes or cost. The paper does not establish that using the broader motor-system model will prevent falls, preserve independence or improve treatment results.
It is also unclear which practical tests should be used routinely, how clinicians should interpret them, and how readily primary care teams can access neuromuscular expertise. The report describes the work as a proposed framework and research agenda; it does not report a clinical trial testing the approach.
Validation Before Practice Changes
The authors call for international working groups that set diagnostic criteria to consider a five-point research agenda. They want practical tests validated for use in clinics, guidelines that support a staged assessment, and trials that measure nerve-related function alongside muscle outcomes.
For now, the paper makes a case for a broader way to frame age-related weakness, not a new standard of care. Whether motor-system measures can identify causes more accurately or guide treatments that improve daily function will depend on future studies.
Key Questions
What is sarcopenia?
Sarcopenia is a condition associated with aging that involves loss of muscle strength and physical function, and often muscle mass. The paper argues that muscle alone may not explain the changes in movement and strength.
What does the paper mean by the motor system?
The motor system refers to the parts of the body involved in producing movement, including the brain, spinal cord, nerves and muscles. The authors say age-related changes across this system may contribute to weakness and mobility loss.
Does the paper show that new screening tests work better?
No. The authors say the suggested measures have not yet been shown to improve outcomes or costs compared with existing screening. They call for validation and clinical trials.
What changes do the authors propose clinicians look for?
They suggest observing how quickly a person rises from a chair, balance during sustained effort, hand dexterity and walking while talking, alongside existing measures such as strength and gait speed. These are proposals, not a validated replacement for current assessment.
Source: medicalxpress.com
